Analysts’ Viewpoint on Chronic Pelvic Pain Treatment Market Scenario
The global chronic pelvic pain treatment market has been witnessing moderate growth since the last few years. This trend is expected to continue during the forecast period. Chronic pelvic pain is caused primarily due to surgery near the pelvic region, cancer (ovarian, uterus, etc.), and pregnancy complications. Demand for various treatments and medications that can reduce pelvic pain has been rising across the globe. Growth in adoption of new treatment procedures such as acupuncture, chiropractic care, biofeedback therapy, and behavioral therapy is projected to drive the global chronic pelvic pain treatment market. Health camps and other government strategies & initiatives to spread awareness about treatments for pelvic pain are also augmenting the market.
Pelvic pain occurs in the pelvic region (the pelvic bone or reproductive organs) in females or males. It is termed chronic when it lasts for six months or more. According to the European Association of Urology (EAU), chronic or persistent pain in structures related to the pelvis of either men or women is termed pelvic pain. Chronic pelvic pain is often associated with behavioral, negative cognitive, and emotional consequences as well as with symptoms indicative of lower urinary tract, pelvic floor, or gynecological dysfunction. Various endoscopic devices are being introduced in the market for accurate diagnosis of chronic pelvic pain. Effective management of chronic pelvic pain care and treatment in healthcare centers is expected to create significant opportunities for market players.
Chronic pelvic pain frequently coexists with non-pelvic pain disorders (e.g. fibromyalgia and migraines) and non-pain comorbidities (e.g. sleep, mood, and cognitive impairment) leading to severe pain and disability. For instance, 50% to 90% of patients with chronic pelvic pain experience musculoskeletal pain and dysfunction. Changes in lifestyle, consumption of hybrid food, increase in pollution, stress, anxiety, and depression could lead to diseases that cause pelvic pain, especially in women. Delay in receiving chronic pelvic pain treatment causes unnecessary suffering from a condition that could be improved with proper management. Rise in awareness about chronic pelvic pain causes and treatment is likely to create growth opportunities for market players.
In terms of treatment, the global chronic pelvic pain treatment market has been classified into medications, surgery, and others. The medications segment has been split into pain relievers, hormone treatments, antibiotics, and antidepressants. The medications segment dominated the global chronic pelvic pain treatment market with around 70% in 2021. The trend is projected to continue during the forecast period. Rise in awareness about the availability of medications for pain management is driving consumption and acceptance of pain management drugs over other treatment options. Medications are the first and primary treatment options provided to patients suffering from chronic pelvic pain. OTC pain relievers are one of the most commonly used drugs in the world. NSAIDs and some other non-opioids such as paracetamol, codeine, ibuprofen, and Aspirin (acetylsalicylic acid) are the most consumed drugs across the globe. According to the FDA, nearly eight in 10 prescriptions filled in the U.S. are for generic drugs. Hence, rise in usage of generic drugs for chronic pelvic pain is expected to drive the market for chronic pelvic pain treatment in the next few years.
Based on distribution channel, the global chronic pelvic pain treatment market has been divided into retail pharmacies & drug stores, e-commerce, and others. The retail pharmacies & drug stores segment held major share of around 65% in 2021. Growth of the segment can be ascribed to the increase in preference for over-the-counter painkillers and other medications in pharmacies and drug stores.
North America accounted for the largest share of around 36% of the global market in 2021, owing to the increase in incidence of chronic pelvic pain in the region. According to the NCBI, one in seven women in the U.S. suffers from chronic pelvic pain. Europe held around 31% share of the global market in 2021. The market in the region is growing at a rapid pace due to the rise in awareness about treatments and increase in number of complete body check-ups. This can help people identify the cause of chronic pelvic pain and avail the correct treatment. Asia Pacific accounted for a larger share of the market than Latin America and Middle East & Africa in 2021. However, the market in Latin America is anticipated to grow at a faster CAGR than that in Middle East & Africa during the forecast period.
The chronic pelvic pain treatment market report concludes with the company profiles section, which includes key information about the leading players in the global chronic pelvic pain treatment market. Leading players in the global chronic pelvic pain treatment market include Bayer AG, Becton, Dickinson and Company, GlaxoSmithKline plc, Hospiinz, Intuitive Surgical, MAST PAK SURGICAL CORP, Mayne Pharma Group Limited, Medtronic, and Perrigo Company plc.
Each of these players has been profiled in the chronic pelvic pain treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 5.7 Bn |
|
Market Forecast Value in 2031 |
More than US$ 8 Bn |
|
Growth Rate (CAGR) |
3.6% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global chronic pelvic pain treatment market was valued at US$ 5.7 Bn in 2021.
The global chronic pelvic pain treatment market is projected to reach more than US$ 8 Bn by 2031.
The global chronic pelvic pain treatment market is anticipated to grow at a CAGR of 3.6% from 2022 to 2031.
The medications segment held more than 70% share of the global chronic pelvic pain treatment market in 2021.
North America is expected to account for major share of the global chronic pelvic pain treatment market during the forecast period.
Prominent players in the global chronic pelvic pain treatment market include Bayer AG, Becton, Dickinson and Company, and GlaxoSmithKline plc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chronic Pelvic Pain Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Chronic Pelvic Pain Treatment Market Overview
5.3. Top 3 players operating in the market space
5.4. Reimbursement Scenario by Region/globally
6. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, by Treatment
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Treatment, 2017–2031
6.3.1. Medications
6.3.1.1. Pain Relievers
6.3.1.2. Hormone Treatments
6.3.1.3. Antibiotics
6.3.1.4. Antidepressants
6.3.2. Surgery
6.3.2.1. Laparoscopic Surgery
6.3.2.2. Hysterectomy
6.3.3. Others
6.4. Market Attractiveness Analysis, by Treatment
7. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031
7.3.1. Retail Pharmacies & Drug stores
7.3.2. E-commerce
7.3.3. Others
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value & Volume Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Chronic Pelvic Pain Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value & Volume Forecast, by Treatment, 2017–2031
9.2.1. Medications
9.2.1.1. Pain Relievers
9.2.1.2. Hormone Treatments
9.2.1.3. Antibiotics
9.2.1.4. Antidepressants
9.2.2. Surgery
9.2.2.1. Laparoscopic Surgery
9.2.2.2. Hysterectomy
9.2.3. Others
9.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031
9.3.1. Retail Pharmacies & Drug stores
9.3.2. E-commerce
9.3.3. Others
9.4. Market Value & Volume Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Treatment
9.5.2. By Distribution Channel
9.5.3. By Country
10. Europe Chronic Pelvic Pain Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Treatment, 2017–2031
10.2.1. Medications
10.2.1.1. Pain Relievers
10.2.1.2. Hormone Treatments
10.2.1.3. Antibiotics
10.2.1.4. Antidepressants
10.2.2. Surgery
10.2.2.1. Laparoscopic Surgery
10.2.2.2. Hysterectomy
10.2.3. Others
10.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031
10.3.1. Retail Pharmacies & Drug stores
10.3.2. E-commerce
10.3.3. Others
10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Treatment
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-region
11. Asia Pacific Chronic Pelvic Pain Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Treatment, 2017–2031
11.2.1. Medications
11.2.1.1. Pain Relievers
11.2.1.2. Hormone Treatments
11.2.1.3. Antibiotics
11.2.1.4. Antidepressants
11.2.2. Surgery
11.2.2.1. Laparoscopic Surgery
11.2.2.2. Hysterectomy
11.2.3. Others
11.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031
11.3.1. Retail Pharmacies & Drug stores
11.3.2. E-commerce
11.3.3. Others
11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Treatment
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-region
12. Latin America Chronic Pelvic Pain Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Treatment, 2017–2031
12.2.1. Medications
12.2.1.1. Pain Relievers
12.2.1.2. Hormone Treatments
12.2.1.3. Antibiotics
12.2.1.4. Antidepressants
12.2.2. Surgery
12.2.2.1. Laparoscopic Surgery
12.2.2.2. Hysterectomy
12.2.3. Others
12.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031
12.3.1. Retail Pharmacies & Drug stores
12.3.2. E-commerce
12.3.3. Others
12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Treatment
12.5.2. By Distribution Channel
12.5.3. By Country/Sub-region
13. Middle East & Africa Chronic Pelvic Pain Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Treatment, 2017–2031
13.2.1. Medications
13.2.1.1. Pain Relievers
13.2.1.2. Hormone Treatments
13.2.1.3. Antibiotics
13.2.1.4. Antidepressants
13.2.2. Surgery
13.2.2.1. Laparoscopic Surgery
13.2.2.2. Hysterectomy
13.2.3. Others
13.3. Market Value & Volume Forecast, by Distribution Channel, 2017–2031
13.3.1. Retail Pharmacies & Drug stores
13.3.2. E-commerce
13.3.3. Others
13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Treatment
13.5.2. By Distribution Channel
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Company Profiles
14.2.1. Bayer AG
14.2.1.1. Company overview
14.2.1.2. Financial overview
14.2.1.3. Business strategies
14.2.1.4. SWOT analysis
14.2.1.5. Recent developments
14.2.2. Becton, Dickinson and Company
14.2.2.1. Company overview
14.2.2.2. Financial overview
14.2.2.3. Business strategies
14.2.2.4. SWOT analysis
14.2.2.5. Recent developments
14.2.3. GlaxoSmithKline plc.
14.2.3.1. Company overview
14.2.3.2. Financial overview
14.2.3.3. Business strategies
14.2.3.4. SWOT analysis
14.2.3.5. Recent developments
14.2.4. Hospiinz
14.2.4.1. Company overview
14.2.4.2. Financial overview
14.2.4.3. Business strategies
14.2.4.4. SWOT analysis
14.2.4.5. Recent developments
14.2.5. Intuitive Surgical
14.2.5.1. Company overview
14.2.5.2. Financial overview
14.2.5.3. Business strategies
14.2.5.4. SWOT analysis
14.2.5.5. Recent developments
14.2.6. MAST PAK SURGICAL CORP
14.2.6.1. Company overview
14.2.6.2. Financial overview
14.2.6.3. Business strategies
14.2.6.4. SWOT analysis
14.2.6.5. Recent developments
14.2.7. Mayne Pharma Group Limited
14.2.7.1. Company overview
14.2.7.2. Financial overview
14.2.7.3. Business strategies
14.2.7.4. SWOT analysis
14.2.7.5. Recent developments
14.2.8. Medtronic
14.2.8.1. Company overview
14.2.8.2. Financial overview
14.2.8.3. Business strategies
14.2.8.4. SWOT analysis
14.2.8.5. Recent developments
14.2.9. Perrigo Company plc
14.2.9.1. Company overview
14.2.9.2. Financial overview
14.2.9.3. Business strategies
14.2.9.4. SWOT analysis
14.2.9.5. Recent developments
List of Tables
Table 01: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 02: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 03: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 06: North America Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 07: Europe Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 09: Europe Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 10: Asia Pacific Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 12: Asia Pacific Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 13: Latin America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 15: Latin America Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 16: Middle East and Africa Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East and Africa Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 18: Middle East and Africa Chronic Pelvic Pain Treatment Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
List of Figures
Figure 01: Global Chronic Pelvic Pain market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 03: Global Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 04: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Medications, 2017–2031
Figure 05: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031
Figure 06: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Others, 2017–2031
Figure 07: Global Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 08: Global Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 09: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Retail Pharmacies & Drug stores, 2017–2031
Figure 10: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by E-commerce, 2017–2031
Figure 11: Global Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, by Others, 2017–2031
Figure 12: Global Chronic Pelvic Pain Treatment Market Value Share Analysis, by Region, 2021 and 2031
Figure 13: Global Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Region, 2022–2031
Figure 14: North America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 15: North America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country, 2021 and 2031
Figure 16: North America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country, 2022–2031
Figure 17: North America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 18: North America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 19: North America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 20: North America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 21: Europe Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 22: Europe Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 23: Europe Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 24: Europe Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 25: Europe Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 26: Europe Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 27: Europe Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 28: Asia Pacific Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 29: Asia Pacific Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 30: Asia Pacific Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 31: Asia Pacific Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 32: Asia Pacific Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 33: Asia Pacific Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 34: Asia Pacific Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 35: Latin America Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 36: Latin America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 37: Latin America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 38: Latin America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 39: Latin America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 40: Latin America Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 41: Latin America Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 42: Middle East and Africa Chronic Pelvic Pain Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 43: Middle East and Africa Chronic Pelvic Pain Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 44: Middle East and Africa Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 45: Middle East and Africa Chronic Pelvic Pain Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 46: Middle East and Africa Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 47: Middle East and Africa Chronic Pelvic Pain Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 48: Middle East and Africa Chronic Pelvic Pain Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Chronic Pelvic Pain Treatment Market
